Skip to main content
Journal ArticleOPEN ACCESS

De novo mTOR inhibitor immunosuppression versus calcineurin inhibitor immunosuppression for liver transplant recipients

Cochrane Database of Systematic Reviews (2023) 2023(8)
DOI: 10.1002/14651858.CD013997
0Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of de novo mTOR inhibitor-based versus calcineurin inhibitor-based immunosuppression for liver transplant recipients.

Cite

CITATION STYLE

APA

Kollbeck, S., Graß, J. K., Hillingsø, J. G., & Penninga, L. (2023). De novo mTOR inhibitor immunosuppression versus calcineurin inhibitor immunosuppression for liver transplant recipients. Cochrane Database of Systematic Reviews, 2023(8). https://doi.org/10.1002/14651858.CD013997

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free